ReviewPsychology research and behavior management2026
"Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations in Schizophrenia": Scoping Review.
Review in Psychology research and behavior management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Auditory verbal hallucinations (AVH) are among the most disabling symptoms of schizophrenia, often resistant to pharmacological treatment. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential non-pharmacological intervention; however, existing evidence is fragmented across heterogeneous study designs. Objective: This scoping review aimed to map the available evidence on the use of rTMS for AVH in patients with schizophrenia, focusing on stimulation parameters, clinical outcomes, neuroimaging findings, and gaps in current research. Methods: A scoping review was conducted following the Joanna Briggs Institute (JBI) methodology and reported in accordance with PRISMA-ScR guidelines. Literature searches were performed in PubMed, Scopus, EBSCO, and ScienceDirect for studies published between 2015 and 2025. Eligible studies included randomized controlled trials (RCTs), observational studies, and exploratory trials investigating rTMS in schizophrenia patients with AVH. Data were extracted and synthesized descriptively. Results: Eight studies met the inclusion criteria. Most were conducted in China, with additional contributions from France, India, and the Netherlands. Low-frequency rTMS (1 Hz) targeting the temporoparietal junction (TPJ) was the most frequently applied protocol, while high-frequency stimulation (10 Hz) over the dorsolateral prefrontal cortex (DLPFC) and cerebellar theta burst stimulation were less common. Several RCTs demonstrated significant reductions in AVH severity, whereas others highlighted placebo effects. Neuroimaging studies reported rTMS-induced modulation of brain connectivity, particularly within the default mode, language, and auditory networks. Across studies, small sample sizes, heterogeneous protocols, and limited follow-up restricted generalizability. Conclusion: rTMS shows promise as a non-pharmacological intervention for AVH in schizophrenia, particularly with low-frequency stimulation over the TPJ. However, evidence remains heterogeneous, and future multicenter trials with standardized protocols and long-term outcomes are warranted to establish clinical effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.